Yondelis

Trabectedin, sold under the brand name Yondelis, is an antitumor chemotherapy medication for the treatment of advanced soft-tissue sarcoma and ovarian cancer.[3][4] The most common adverse reactions include nausea, fatigue, vomiting, constipation, decreased appetite, diarrhea, peripheral edema, dyspnea, and headache.[3][4] It is sold by Pharma Mar S.A. and Johnson and Johnson. It is approved for use in the European Union, Russia,... [wikipedia]